Eleni Efstathiou, MD, PhD

Houston Methodist Cancer Center

Articles by Eleni Efstathiou, MD, PhD

Andrew Laccetti, MD, MSCRPC | September 25, 2024
Experts at ESMO Congress 2024 discuss novel therapies for castration-resistant prostate cancer.
View More
Andrew Laccetti, MD, MSCRPC | September 25, 2024
Experts review the CONTACT-02 trial as well as the Decipher score utilized in the STAMPEDE trial.
Andrew Laccetti, MD, MSCRPC | September 25, 2024
The roundtable of experts discuss the realities of the SPLASH trial's hazard ratio and overall survival results.
Andrew Laccetti, MD, MSmCSPC | September 25, 2024
At ESMO 2024, experts discuss androgen-deprivation therapy in HSPC as well as the ARANOTE trial.
Andrew Laccetti, MD, MSCRPC | September 25, 2024
Experts at ESMO 2024 discuss the implications and insights associated with the Peace III trial.
Andrew Laccetti, MD, MSmHSPC | September 25, 2024
Experts discuss mHSPC discuss risk stratification, developed novel approaches for treatment, and treatment sequencing.